MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA) clearance and the ...
BOSTON — Pulling a medical device off the market is one thing. Removing it from the bodies of thousands of patients is a lot more complicated and dangerous. Consider the Sprint Fidelis, a heart ...
In 2007 Medtronic stopped selling the Sprint Fidelis, a heart defibrillator cable, after five patients who had the cables died. But only now is the full scope of the public health problem becoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback